Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2CNS 2NET 1Genitourinary 1Endocrine 1Breast 1

Conditions

Carcinoma, Hepatocellular 2Brain Neoplasms 2Prostatic Neoplasms 1Neuroendocrine Tumors 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 1023Carboplatin 964Paclitaxel 933Gemcitabine 794Cisplatin 751Docetaxel 683Bevacizumab 609Pemetrexed 502Nivolumab 487Cyclophosphamide 471Capecitabine 461Fluorouracil 418Dexamethasone 403Rituximab 372Oxaliplatin 348Injections 345atezolizumab 298Trastuzumab 298Leucovorin 288Cetuximab 282Irinotecan 268130-nm albumin-bound paclitaxel 254Prednisone 245Doxorubicin 240Ipilimumab 226Lenalidomide 220fludarabine 218Fulvestrant 217durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × gadoterate meglumine × Clear all
NCT06057168 2026-01-29

GDX-44-016

Guerbet

Phase 3 Completed
138 enrolled 7 charts
CNS

Brain Neoplasms

NCT04373564 2026-01-22

ODYSSEY

Guerbet

Phase 4 Recruiting
2,076 enrolled
BreastEndocrineGastrointestinalGenitourinaryNET

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

NCT01806740 2019-08-08

DCE-MRI

Guerbet

Phase 4 Terminated
37 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02034708 2016-12-30

REMIND

Guerbet

Phase 4 Completed
279 enrolled 9 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡